Literature DB >> 30466122

Primary Sclerosing Cholangitis and Psychological Wellbeing: A Scoping Review.

Veronica Ranieri1,2, Kathy McKay1,3, Martine Walmsley4, Robert Senior1, Douglas Thorburn5, Eilis Kennedy1,6.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic liver disease resulting from the inflammation and scarring of an individual's hepatic bile ducts. With no curative treatment available and a risk of potentially severe complications and death, it is likely that those diagnosed with the illness may experience impairments in their psychological wellbeing. The aim of this scoping review is to locate, chart, and summarize all available literature on how PSC affects mental health and psychological wellbeing, as well as the factors that may or may not impact on the psychological wellbeing of those who have this diagnosis. This exercise identified five key themes within the literature: prevalence and characteristics of mental health problems, quality of life, unmet needs, medical treatment, and biomarkers. Three key recommendations for clinical practice emerge from this review. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 30466122     DOI: 10.1055/s-0038-1676099

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  4 in total

Review 1.  Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.

Authors:  Alberto Nicoletti; James B Maurice; Douglas Thorburn
Journal:  Frontline Gastroenterol       Date:  2020-03-02

2.  Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing cholangitis: a protocol.

Authors:  Veronica Ranieri; Eilis Kennedy; Martine Walmsley; Doug Thorburn; Kathy McKay
Journal:  BMJ Open       Date:  2019-10-02       Impact factor: 2.692

3.  Quality of life in primary sclerosing cholangitis: a systematic review.

Authors:  Elena Marcus; Paddy Stone; Anna-Maria Krooupa; Douglas Thorburn; Bella Vivat
Journal:  Health Qual Life Outcomes       Date:  2021-03-20       Impact factor: 3.186

4.  Increased risk of cancer in patients with primary sclerosing cholangitis.

Authors:  Aiva Lundberg Båve; Annika Bergquist; Matteo Bottai; Anna Warnqvist; Erik von Seth; Caroline Nordenvall
Journal:  Hepatol Int       Date:  2021-08-06       Impact factor: 6.047

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.